Search for a clinical study
Alnylam ALN-APP-001: Phase I, Placebo-Controlled Trial of ALN-APP in Participants with Early-Onset Alzheimer’S Disease
Who is Eligible Ages 18+ Must have had symptoms of Alzheimer’s disease prior to age 65 Diagnosis of Alzheimer’s disease Must be able to complete MRI Must be able to tolerate lumbar puncture No history of ...
1011003300 National Cell Repository for Alzheimer's Disease
Does more than one member of your family have Alzheimer’s disease or serious memory loss? Your family can be an essential part of Alzheimer's disease research by participating in the ...
1011003338 Indiana Alzheimer Disease Core Center
The purpose of this program is to identify, evaluate, study, and follow persons who have Alzheimer's disease, those who have other disorders of memory and thinking, and older individuals who ...
A Phase 1B/2, Multicenter, Adaptive, Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety, Tolerability, Immunogenicity, and Pharmacodynamic Effects of ACI-24.060 in Subjects with Prodromal Alzheimer's ...
?The purpose of this study is to assess the safety, tolerability, immunogenicity and pharmacodynamic effects of ACI-24.060 in subjects with prodromal Alzheimer's disease and in non-demented adults with Down syndrome.This ...
Parkinson's Progression Markers Initiative 2.0 Remote Study
The purpose of PPMI 2.0 Remote is to find out if information collected remotely (by internet, mail, home visits, or phone applications) can help identify individuals at an increased risk ...
The Assessment of Smart Phone Everyday Tasks (ASSET): a New IADL Test for Early AD
The overall goal of this project is to validate a novel performance-based IADL instrument that uses a smartphone to assess healthcare-related daily activities, ASSET. This IADL test has been designed ...
Impact of Intravitreal Pegcetacoplan Treatment on Systemic Complement Levels in Age Related Macular Degeneration: a Pilot Study
This study aims to understand how a new eye treatment, Pegcetacoplan, affects levels of certain proteins in the blood (complement proteins) that are linked to age-related macular degeneration and to ...
A Pivotal, Prospective, Open-Label, Multi-Center Study of Safety and Effectiveness of Cochlear Implantation in an Expanded Population of Adults with Bilateral Sensorineural Hearing Loss
This study aims to evaluate the safety and efficacy of cochlear implantation for adults with bilateral sensorineural hearing loss who currently do not meet the FDA-approved indications for cochlear implantation. ...
Autosomal Dominant Osteopetrosis: a Natural History Study
?Physicians at Indiana University want to learn more about Osteopetrosis, especially Autosomal Dominant Osteopetrosis. Osteopetrosis is a rare metabolic bone disease that can cause hard bones that can break easily. Not enough ...
Join Us in Advancing Alzheimer’S Research—Your Blood Sample Can Make a Difference
One Blood Sample. One Visit. A Big Impact.The Indiana Biobank is a research program that began in 2010 through the Indiana University School of Medicine and IU Health. You can ...